Join the Rhinitis group to help and get support from people like you.
Rhinitis News
Xhance Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
YARDLEY, Pa., March 15, 2024 (GLOBE NEWSWIRE) – Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
FDA Approves Tris Pharma's New Drug Application for Karbinal ER
MONMOUTH JUNCTION, N.J., April 3, 2013 /PRNewswire/ – Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food...
MEDA Announces Dymista Approved by the FDA
Göteborg, Sweden--(BUSINESS WIRE)--May 2, 2012 – The U.S. Food and Drug Administration (FDA) has approved Dymista, a new patented product for treatment of seasonal allergic rhinitis (SAR). In ...
Meda Receives FDA Approval of New Astepro (azelastine HCl) Nasal Spray 0.15%, the First and Only Once-Daily Nasal Antihistamine
SOMERSET, N.J., Sept. 2 /PRNewswire/ – Meda Pharmaceuticals Inc. today announced that the US Food and Drug Administration (FDA) has approved Astepro (azelastine HCl) Nasal Spray 0.15%, for the...
Ask a question
To post your own question to this support group, sign in or create an account.